![]()
07.09.20151298
The study evaluated the safety and efficacy of a regimen of P2Y12 inhibitor cangrelor followed by clopidogrel compared with clopidogrel alone in patients who underwent PCI with transradial or transfemoral access.
![]()
04.09.20151476
AstraZeneca announced that a 60 mg twice-daily dose of its antiplatelet agent ticagrelor has been approved by the FDA for prevention of CV death, MI and stroke in patients more than 1 year after an ACS event.
![]()
03.09.20151622
The early addition of aldosterone inhibition to standard care for patients with acute MI without HF did not reduce the risk for adverse outcomes, according to results from the ALBATROSS study presented at the European Society of Cardiology Congress.
![]()
02.09.20151866
Chief Medical Editor of Cardiology Today’s Intervention, discusses results of the OPTIDUAL Hot Line trial of dual antiplatelet therapy after drug-eluting stent implantation and provides his opinion on future research to determine the optimal duration of therapy in this population.
![]()
02.09.20151662
Use of thrombectomy to retrieve larger thrombi improved neurological recovery at discharge in patients with acute ischemic stroke, according to a substudy of the MR CLEAN trial.
![]()
31.08.20154728
RSC Board of Educational programmes together with European Society of Cardiology releases ESC webinars with Russian subtitles.
![]()
31.08.20151340
Deterioration of renal function, and an increase in related adverse events, may not be unusual in patients with nonvalvular atrial fibrillation prescribed nonvitamin K antagonist oral anticoagulants, according to recent study results in Heart and Vessels.
